||||||||||Sputnik-V (Gam-COVID-Vac Lyo) / Gamaleya Research Institute [VIRTUAL] COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DISEASE OUTCOMES AND FIRST VACCINATION DATA IN RUSSIAN FEDERATION () - May 13, 2021 - Abstract #EHA2021EHA_1310; P=N/A Anticoagulants, corticosteroids and IL-6 inhibitors were introduced mainly during 2nd wave while hydroxychloroquine was abandoned (fig.1)...Older age is a factor of moderate/severe disease course. The TKI impact on COVID-19 course and post-vaccination immunity in CML pts need to be studied.